ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Baltimore, MD, USA:

Niraparib + Dostarlimab In BRCA Mutated Breast Cancer

This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...

Enrolling
Breast Cancer
Stage II Breast Cancer
Drug: Niraparib
Drug: Dostarlimab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Baltimore, Maryland, United States and 8 other locations

radiation treatment after undergoing a lumpectomy, also known as "breast conserving surgery". In this trial, we are attempting to identify w...

Active, not recruiting
Breast Cancer Radiation
Device: Prosigna

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Baltimore, Maryland, United States and 5 other locations

This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...

Active, not recruiting
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
Drug: Olaparib

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Baltimore, Maryland, United States and 19 other locations

This study is being done to look at the role of continuing palbociclib treatment in combination with another type of hormonal therapy (fulvestrant) a...

Active, not recruiting
Metastatic Breast Cancer
Drug: Palbociclib
Drug: Fulvestrant

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States and 4 other locations

This is a multi-institutional pilot trial for patients with advanced breast cancer. The trial is designed to assess the safety and ...

Active, not recruiting
Breast Cancer
Drug: Avelumab
Drug: Talazoparib

Phase 1, Phase 2

Georgetown University
Georgetown University

Washington, District of Columbia, United States and 1 other location

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting
Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States and 9 other locations

triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...

Enrolling
Hormone Receptor Positive (HR+), HER2-negative Breast Cancer
Triple Negative Breast Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 2

Laura M. Spring, MD

Baltimore, Maryland, United States and 9 other locations

Locations recently updated

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

Bethesda, Maryland, United States and 12 other locations

The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...

Enrolling
Metastatic Breast Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Phase 3

DualityBio

Fairfax, Virginia, United States and 44 other locations

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...

Active, not recruiting
Breast Cancer
Drug: ARV-471 in combination with Everolimus

Phase 1

Arvinas
Arvinas

Washington, District of Columbia, United States and 8 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems